MaxCyte and KSQ Therapeutics announce development and commercialization agreement
GAITHERSBURG: MaxCyte Inc. and KSQ Therapeutics announced that the companies have entered into a new development and commercialization agreement. Under the agreement, KSQ gains rights to use MaxCyte’s Flow Electroporation…